Smith Group Asset Management’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
Other funds holding PAHC
Smith Group Asset Management's PAHC Position: Q3 2026 in Review
Smith Group Asset Management increased its Phibro Animal Health (PAHC) stake by 1.7% in Q3 2026, buying an estimated $15.4K and bringing the position to 25,846 shares worth $924K. The position accounts for 0.06% of the portfolio, ranked #75.
Smith Group Asset Management first reported a position in PAHC in Q3 2018 and has held it in 11 quarters since. The position peaked at $1.38M in Q1 2026. 47 funds tracked by Wall St. Rank hold PAHC as of Q3 2026.
- Smith Group Asset Management held 25,846 shares of Phibro Animal Health worth $924K as of Q3 2026.
- Smith Group Asset Management bought 439 Phibro Animal Health shares in Q3 2026, an estimated $15.4K.
- Phibro Animal Health made up 0.06% of Smith Group Asset Management's portfolio in Q3 2026, its #75 holding.
- Smith Group Asset Management first reported a position in Phibro Animal Health in Q3 2018 and has held it in 11 quarters since.
- Smith Group Asset Management's Phibro Animal Health position peaked at $1.38M in Q1 2026.
- 47 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2026.
Based on Smith Group Asset Management's 13F filing for Q3 2026, filed 27 Oct 2026.